Soothion Psoriasis and Seborrheic Dermatitis Formula

Manufacturer
Electrolyzed Innovations, LLC | TropiChem Research Labs, Inc.
Effective date
2019-12-23
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:02:18

Label at a glance#

ProductSoothion Psoriasis and Seborrheic Dermatitis Formula
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

Controls and helps eliminate recurrence of: skin itching irritation redness flaking and scaling associated with psoriasis and seborrheic dermatitis.

Dosage and administration

apply to affected areas one to four times daily or as directed by a doctor.

Storage and handling

Store in a cool, dry place below 77°F Protect from heat and light

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Psoriasis / Seborrheic Dermatitis

Uses

INDICATIONS & USAGE SECTION

Controls and helps eliminate recurrence of:
  • skin itching
  • irritation
  • redness
  • flaking and scaling associated with psoriasis and seborrheic dermatitis.

Warnings

WARNINGS SECTION

For external use only.

Ask a doctor before use

OTC - ASK DOCTOR SECTION

  • if condition covers a large area of the body.

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes. If contact occurs rinse eyes thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens or does not improve after regular use of this product as directed.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding ask a doctor before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • apply to affected areas one to four times daily or as directed by a doctor.

Other information

STORAGE AND HANDLING SECTION

  • Store in a cool, dry place below 77°F
  • Protect from heat and light

Inactive ingredients

INACTIVE INGREDIENT SECTION

arnica montana flower, calendula officinalis flower, cannabis sativa seed oil, emulsifying wax, horse chestnut, imidazolidinyl urea, sheanut oil, spearmint oil, stearic acid, water

DESCRIPTION SECTION


Manufactured for Electrolyzed Innovations, LLC
(866) 528-3721   2214 Wilshire Dr, Piqua, OH 45356 USA

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


Psoriasis and Seborrheic Dermatitis Formula

Soothion

Ion Dispersion Formula Designed to Relieve

  • Itching
  • Redness
  • Irritation
  • Flaking
  • Scaling


Net Wt. 8 oz ( 226 g )                  Made in USA

Soothion Psoriasis LabelSoothion Psoriasis Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
103568salicylic acid 2 % Topical LotionPSN2
103568salicylic acid 20 MG/ML Topical LotionSCD2
103568salicylic acid 2 % Topical LotionSY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69031-004-082022-01-28C16284748780-1d6a99b39-6b7d-a426-e053-dadaa90af4c2Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69031-004-08Soothion Psoriasis and Seborrheic Dermatitis Formula226 g in 1 BOTTLELOTION2262

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69031-004SOOTHION PSORIASIS AND SEBORRHEIC DERMATITIS FORMULA (SALICYLIC ACID) LOTION [ELECTROLYZED INNOVATIONS, LLC]2Legacy NDC, 1 package rows20191224_b64d3b37-4242-4779-9a47-957b04ff384d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZ1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1
ARNICA MONTANA FLOWERINACTIVE INGREDIENTOZ0E5Y15PZ1
CALENDULA OFFICINALIS FLOWERINACTIVE INGREDIENTP0M7O4Y7YD1
CANNABIS SATIVA SEED OILINACTIVE INGREDIENT69VJ1LPN1S1
HORSE CHESTNUTINACTIVE INGREDIENT3C18L6RJAZ1
IMIDUREAINACTIVE INGREDIENTM629807ATL1
SHEANUT OILINACTIVE INGREDIENTO88E196QRF1
SPEARMINT OILINACTIVE INGREDIENTC3M81465G51
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69031-00469031-004-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 36 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
STEARIC ACIDSTEARIC ACID4ELV7Z65APSHAMPOO / TOPICAL9.7 %w/wExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL360 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, FILM COATED / ORAL176 mgExact identifier — unii candidate
26 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLLOTION / TOPICAL228 mgExact identifier — unii candidate
3 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, COATED / ORAL42.4 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCAPSULE / ORAL90 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCAPSULE, EXTENDED RELEASE / ORAL64 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APPOWDER, FOR SUSPENSION / ORAL1203 mg/5mlExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APPELLET / SUBCUTANEOUS0.97 mgExact identifier — unii candidate
26 equally ranked IID candidates
SPEARMINT OILSPEARMINT OILC3M81465G5SYRUP / ORALNAExact identifier — unii candidate
7 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, DELAYED RELEASE / ORAL80 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, EXTENDED RELEASE / ORAL200 mgExact identifier — unii candidate
26 equally ranked IID candidates
SPEARMINT OILSPEARMINT OILC3M81465G5TABLET / SUBLINGUAL0.4 mgExact identifier — unii candidate
7 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APSOAP / TOPICAL6 %w/wExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET / BUCCAL6 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, FILM COATED, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET / ORAL336 mgExact identifier — unii candidate
26 equally ranked IID candidates
SPEARMINT OILSPEARMINT OILC3M81465G5CAPSULE / ORALNAExact identifier — unii candidate
7 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET / SUBLINGUAL9 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APAEROSOL, FOAM / TOPICAL70 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, ORALLY DISINTEGRATING / ORAL10 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APSOLUTION / TOPICALNAExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, CHEWABLE / ORAL180 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APAEROSOL, FOAM / VAGINAL4 %w/wExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APEMULSION / TOPICALNAExact identifier — unii candidate
26 equally ranked IID candidates
SPEARMINT OILSPEARMINT OILC3M81465G5SUSPENSION / ORAL0.59 mg/20mlExact identifier — unii candidate
7 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / VAGINAL1088 mgExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APOINTMENT / TOPICAL15 %w/wExact identifier — unii candidate
26 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLSHAMPOO / TOPICAL120 mgExact identifier — unii candidate
3 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APIMPLANT / SUBCUTANEOUS1.04 mgExact identifier — unii candidate
26 equally ranked IID candidates
SPEARMINT OILSPEARMINT OILC3M81465G5OINTMENT / TOPICALNAExact identifier — unii candidate
7 equally ranked IID candidates
SPEARMINT OILSPEARMINT OILC3M81465G5PASTE, DENTIFRICE / DENTAL27.6 %w/wExact identifier — unii candidate
7 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APEMULSION / ORALNAExact identifier — unii candidate
26 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APLOTION / TOPICAL80 mgExact identifier — unii candidate
26 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLCREAM / TOPICAL0.4 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
SPEARMINT OILSPEARMINT OILC3M81465G5SOLUTION / ORALNAExact identifier — unii candidate
7 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9a66542f-9dc4-2f00-e053-2995a90ac130b64d3b37-4242-4779-9a47-957b04ff384d2019-12-23WarningsExact identifier
spl id: 9a66542f-9dc4-2f00-e053-2995a90ac130
spl set id: b64d3b37-4242-4779-9a47-957b04ff384d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.